Skyepharma Production S.A.S

About Skyepharma Production S.A.S

Skyepharma is an expert CDMO specialized in formulating, developing and producing complex oral dosage forms, with complex and tailor-made modified release profiles.
We offer a full range of services, from early stage development to industrial manufacturing and packaging.

Our scientific expert team, supported by our patented technologies, has a solid track-record of successful development, reformulation and transfer projects.
Our GMP site located in France, FDA approved, serve worldwide customers, with a recognized high level of service.

  • FR
  • 2017
    On CPHI since
Contact info
  • Z.A de Chesnes Ouest , 55 Rue du Montmurier B.P 45, 38070, Saint-Quentin-Fallavier, France
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Skyepharma Production S.A.S (5)

  • Early stage formulation Development & Process Design

    Product Early stage formulation Development & Process Design

    We have extensive experience in solving complex formulation challenges. Our experts can apply our extensive range of proprietary technologies for immediate (IR) and modified (MR) / sustained, slow (SR) / controlled (CR) / extended (XR, ER) / pulsed / timed release as well as enteric and gastro reten...
  • Clinical trial material (CTM) manufacturing and release

    Product Clinical trial material (CTM) manufacturing and release

    We offer capabilities for manufacturing of small and large scale clinical trial material (CTM) as well as characterization and release from phase 1 to phase 3.
  • Manufacturing of complex and classic oral solid dosage forms

    Product Manufacturing of complex and classic oral solid dosage forms

    Manufacturing of classic and complex oral solid dosage forms:  single layer tablets, multi-layer tablets, tab-in-tab, tab-in-caps, hard gel capsules, powder & pellets.
  • Analytical Development and expertise

    Product Analytical Development and expertise

    Our analytical experienced team support the pharmaceutical development during every phase of the development process. Analytical development transfer and validation, characterization capabilities, stability analysis, ICH Q3D (residuals solvent risk assesment), ICHQ3C (elemental impurities risk assesment...
  • Scale-up and Quality by Design (QbD) processes

    Product Scale-up and Quality by Design (QbD) processes

    Skyepharma is experienced with the scale-up of complex oral solid dosage forms from laboratory to pilot-scale and full commercial scale manufacturing. We have powerfull compaction simulation tools ( STYL'One evolution) allowing to derisk and fasten scale-up steps. 
    Our capabilities :...

Skyepharma Production S.A.S Resources (2)